Exact Mass: 333.2304

Exact Mass Matches: 333.2304

Found 27 metabolites which its exact mass value is equals to given mass value 333.2304, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

2-(4-{2-[4-(2,2-dimethylbutyl)-3H-imidazol-2-yl]ethyl}phenyl)pyridine

C22H27N3 (333.2205)


   

Carbetapentane

2-[2-(diethylamino)Ethoxy]ethyl 1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylate

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


   

Stearidonoyl glycine

2-(6Z,9Z,12Z,15Z)-octadeca-tetraenamidoacetic acid

C20H31NO3 (333.2304)


   
   

Pentoxyverine

carbetapentane

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

carbetapentane

carbetapentane

C20H31NO3 (333.2304)


   

N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide

N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide

C17H28BN3O3 (333.2224)


   

2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester

2-(2-Morpholinoethylamino)pyridine-5-boronic acid pinacol ester

C17H28BN3O3 (333.2224)


   

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine

N-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine

C19H29BFNO2 (333.2275)


   

trans-4-[5-(4-Pentylcyclohexyl)-2-pyrimidinyl]benzonitrile

trans-4-[5-(4-Pentylcyclohexyl)-2-pyrimidinyl]benzonitrile

C22H27N3 (333.2205)


   

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOHEXANAMINE

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)CYCLOHEXANAMINE

C19H29BFNO2 (333.2275)


   

1-METHYL-2,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE

1-METHYL-2,5-BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE

C17H29B2NO4 (333.2283)


   

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

2-(4-(2-(4-(2,2-Dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)pyridine

C22H27N3 (333.2205)


   

5-(2-(6-Methyl-3-pyridyl)ethyl)-2-propyl-1,2,3,4-tetrahydro-gamma-carboline

5-(2-(6-Methyl-3-pyridyl)ethyl)-2-propyl-1,2,3,4-tetrahydro-gamma-carboline

C22H27N3 (333.2205)


   

2-(4-(8-Chloro-3,7-dimethylocta-2(E),6(E)-dienyl)-1,3,3-trimethyl-1-cyclohexen-2-YL)acetonitrile

2-(4-(8-Chloro-3,7-dimethylocta-2(E),6(E)-dienyl)-1,3,3-trimethyl-1-cyclohexen-2-YL)acetonitrile

C21H32ClN (333.2223)


   

NA-Gly 18:4(6Z,9Z,12Z,15Z)

NA-Gly 18:4(6Z,9Z,12Z,15Z)

C20H31NO3 (333.2304)


   
   
   

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

2,2,2-trifluoro-1-(2-methyl-3-undecyl-4,5-dihydropyrrol-1-yl)ethanone

2,2,2-trifluoro-1-(2-methyl-3-undecyl-4,5-dihydropyrrol-1-yl)ethanone

C18H30F3NO (333.2279)